Loading...
ROCO
4911
Market cap55mUSD
Jul 09, Last price  
32.30TWD
1D
-3.87%
1Q
-14.78%
Jan 2017
-59.68%
IPO
-53.63%
Name

G&E Herbal Biotechnology Co Ltd

Chart & Performance

D1W1MN
ROCO:4911 chart
P/E
12.92
P/S
5.82
EPS
2.50
Div Yield, %
2.34%
Shrs. gr., 5y
1.60%
Rev. gr., 5y
61.39%
Revenues
309m
+24.13%
25,031,00020,450,00030,461,00029,264,00028,471,00025,713,00031,105,00043,068,00076,631,00054,074,00034,511,00021,847,0002,200,00017,554,00028,230,00024,571,00064,607,000181,443,000249,033,000309,132,000
Net income
139m
+36.38%
-11,910,000-11,765,000-1,387,000-1,513,000-10,452,0005,717,000-11,684,000-3,829,00013,701,000-11,872,000-14,596,000-41,684,000-22,623,000-23,365,000-14,302,000-19,884,0007,381,00072,400,000102,063,000139,197,000
CFO
70m
-47.89%
-19,405,000771,000-9,191,00099,963,000113,482,000134,676,00070,177,000
Dividend
Jul 29, 20250.75691 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

G&E Herbal Biotechnology Co., Ltd. operates as a biopharmaceutical enterprise, concentrating on the innovation and commercialization of advanced botanical extraction technologies and the products derived from them. Its diverse portfolio features a range of botanical anti-aging cosmetic items, including facial foam cleansers, cleansing essences, toners, lightening lotions, essential oils, and moisturizing serums and creams, along with specialized products like the SR-100 botanical essence and bromelain illuminating cleansing mousse. The company also manufactures capsules designed as hepato-protective agents. In the realm of wellness, G&E offers a selection of botanical healthcare products such as ArthrEnergy, Jujubes Polysaccharide, Diabecut, HepatoClean, Astragali Radix, Goji, Prosta, and SR-100 capsules, as well as various products catering to adults. Looking to its future developments, the company is actively pursuing new treatments, including Solarise injection for gynecologic, head, and neck cancers; Apocin capsules intended for non-small cell lung cancer; and SR-T100 Gel, which targets common and genital warts. Beyond its own product lines, G&E Herbal Biotechnology is involved in creating manufacturing technologies for a wide array of dietary supplements and provides expert technical advisory services to other biotechnology organizations. The company was founded in 2002 and is headquartered in Tainan City, Taiwan.
IPO date
Apr 28, 2008
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT